Champions Oncology (CSBR) vs Eloxx Pharmaceuticals (ELOX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Champions Oncology is the larger company by market cap ($67.9 million vs $60.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSBR | ELOX |
|---|---|---|
| Share price | $4.88 | $14.88 |
| Market cap | $67.92M | $60.06M |
| 1-day change | -2.59% | -1.65% |
| YTD return | -29.38% | — |
| 1-year return | -25.38% | — |
| 5-year return | -51.59% | — |
| P/E ratio (TTM) | — | 4.23 |
| Forward P/E | 48.80 | — |
| EPS (TTM) | $-0.07 | $3.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.31 | $23.40 |
| 52-week low | $4.59 | $8.20 |
| Distance from 52-week high | -41.28% | -36.41% |
| Average volume | 11.25K | 46.88K |
| Shares outstanding | 13.92M | 4.04M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CSBR vs ELOX FAQ
Which is bigger, Champions Oncology or Eloxx Pharmaceuticals?
Champions Oncology (CSBR) is larger, with a market capitalization of $67.92M compared with $60.06M for Eloxx Pharmaceuticals (ELOX).
Are Champions Oncology and Eloxx Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.